138 related articles for article (PubMed ID: 26358468)
1. A lectin-based diagnostic system using circulating antibodies to detect cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Glycobiology; 2016 Jan; 26(1):100-7. PubMed ID: 26358468
[TBL] [Abstract][Full Text] [Related]
2. Increased sialylation and reduced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix.
Jin Y; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Clin Chem Lab Med; 2016 Nov; 54(11):1811-1819. PubMed ID: 27092648
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.
Mathur SP; Mathur RS; Underwood PB; Kohler MF; Creasman WT
Gynecol Oncol; 2003 Dec; 91(3):486-93. PubMed ID: 14675666
[TBL] [Abstract][Full Text] [Related]
4. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
5. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
6. Serum Immune Profiling for Early Detection of Cervical Disease.
Ewaisha R; Panicker G; Maranian P; Unger ER; Anderson KS
Theranostics; 2017; 7(16):3814-3823. PubMed ID: 29109779
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
8. Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer.
Maestri CA; Nisihara R; Ramos GP; Weinschutz Mendes H; Messias-Reason I; de Carvalho NS
Med Princ Pract; 2017; 26(6):530-534. PubMed ID: 29131134
[TBL] [Abstract][Full Text] [Related]
9. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
11. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
12. Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.
Mathur SP; Mathur RS; Young RC
Am J Reprod Immunol; 2000 Oct; 44(4):222-30. PubMed ID: 11076094
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
Yang S; Cheng H; Huang Z; Wang X; Wan Y; Cai J; Wang Z
Dis Markers; 2015; 2015():506428. PubMed ID: 25873749
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between the Serum Level of Selenium and Cervical Intraepithelial Neoplasia: A Comparative Study in a Population of Nigerian Women.
Obhielo E; Ezeanochie M; Olokor O O; Okonkwo A; Gharoro E
Asian Pac J Cancer Prev; 2019 May; 20(5):1433-1436. PubMed ID: 31127904
[TBL] [Abstract][Full Text] [Related]
15. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia.
Chay DB; Cho H; Kim BW; Kang ES; Song E; Kim JH
Obstet Gynecol; 2013 Feb; 121(2 Pt 1):321-329. PubMed ID: 23344282
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer.
Jeong NH; Woo MK; Lee NW; Hur SJ; Choi KS; Kim HJ
Arch Pharm Res; 2009 Jul; 32(7):1013-8. PubMed ID: 19641882
[TBL] [Abstract][Full Text] [Related]
19. Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer.
Jin Y; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
Arch Pharm Res; 2018 Apr; 41(4):438-449. PubMed ID: 29492827
[TBL] [Abstract][Full Text] [Related]
20. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
Pretorius RG; Peterson P; Azizi F; Burchette RJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1260-5. PubMed ID: 17074547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
